FINDING THE OPTIMAL TREATMENT STRATEGY FOR DISEASE ACTIVITY-GUIDED DOSE REDUCTION OF ADALIMUMAB AND ETANERCEPT IN RHEUMATOID ARTHRITIS: A MODELLING STUDY

被引：0
|
作者：
Verhoef, L. M. [1 ]
Bos, D. P. [1 ]
van den Ende, C. H. [1 ,2 ]
van den Hoogen, F. H. [1 ,2 ]
Fautrel, B. [3 ]
Hulscher, M. E. [4 ]
Kievit, W. [5 ]
den Broeder, A. A. [1 ,2 ]
机构：
[1] St Maartenskliniek, Rheumatol, Nijmegen, Netherlands
[2] Radboudumc, Rheumatol, Nijmegen, Netherlands
[3] Hop La Pitie Salpetriere, Rheumatol, Paris, France
[4] RIHS, IQ Healthcare, Nijmegen, Netherlands
[5] Radboudumc, RIHS, Hlth Evidence, Nijmegen, Netherlands
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷
关键词：
D O I：
10.1136/annrheumdis-2018-eular.2604
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0207
引用
收藏
页码：323 / 323
页数：1
相关论文
共 50 条
  • [1] Finding the Optimal Treatment Strategy for Disease Activity-Guided Dose Reduction of Adalimumab and Etanercept in Rheumatoid Arthritis: A Modelling Study
    Bos, D. P. G.
    Verhoef, L. M.
    van den Ende, C. H. M.
    van den Hoogen, F. H. J.
    Fautrel, Bruno
    Hulscher, M. E. J. L.
    Kievit, W.
    Den Broeder, A. A.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [2] Disease activity-guided dose optimisation of adalimumab and etanercept is a cost-effective strategy compared with non-tapering tight control rheumatoid arthritis care: analyses of the DRESS study
    Kievit, Wietske
    van Herwaarden, Noortje
    van den Hoogen, Frank H. J.
    van Vollenhoven, Ronald F.
    Bijlsma, Johannes W. J.
    van den Bemt, Bart J. F.
    van der Maas, Aatke
    den Broeder, Alfons A.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (11) : 1939 - 1944
  • [3] A Dose-Finding Study of Etanercept for Treatment of Rheumatoid Arthritis
    不详
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 (01) : 13 - 13
  • [4] Effectiveness of dose reduction of etanercept and adalimumab in patients with rheumatoid arthritis
    Rosalía Martínez-Pérez
    Sergio Rodríguez-Montero
    Alejandro Muñoz
    Julia Uceda
    Mario León
    Francisco Gallo
    Maria Luisa Velloso
    José Luis Marenco
    Journal of Translational Medicine, 9 (Suppl 2)
  • [5] Optimal dose of etanercept in the treatment of rheumatoid arthritis
    Curtis, Elizabeth Mary
    Marks, Jonathan Lewis
    OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS, 2014, 6 : 27 - 38
  • [6] A Pilot Dose-Finding Study of Etanercept in Rheumatoid Arthritis
    Breedveld, Ferdinand C.
    Jones, Heather E.
    Peifer, Kim
    Korth-Bradley, Joan
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2018, 11 (01): : 38 - 45
  • [7] Disease activity guided dose reduction and withdrawal of adalimumab or etanercept compared with usual care in rheumatoid arthritis: open label, randomised controlled, non-inferiority trial
    van Herwaarden, Noortje
    van der Maas, Aatke
    Minten, Michiel J. M.
    van den Hoogen, Frank H. J.
    Kievit, Wietske
    van Vollenhoven, Ronald F.
    Bijlsma, Johannes W. J.
    van den Bemt, Bart J. F.
    den Broeder, Alfons A.
    BMJ-BRITISH MEDICAL JOURNAL, 2015, 350
  • [8] Randomised Controlled Non-Inferiority Study of Dose Reduction and Withdrawal of Adalimumab and Etanercept in Rheumatoid Arthritis.
    van Herwaarden, Noortje
    van der Maas, Aatke
    Minten, Michiel
    van den Hoogen, Frank H. J.
    van Vollenhoven, Ronald F.
    Bijlsma, Johannes W. J.
    van den Bemt, Bart
    den Broeder, Alfons A.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S810 - S811
  • [9] Adalimumab and etanercept serum (anti)drug levels are not predictive for successful dose reduction or discontinuation in rheumatoid arthritis
    van Herwaarden, Noortje
    Bouman, Chantal A. M.
    van der Maas, Aatke
    van Vollenhoven, Ronald F.
    Bijlsma, Johannes W.
    van den Hoogen, Frank H. J.
    den Broeder, Alfons A.
    van den Bemt, Bart J. F.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (12) : 2260 - +
  • [10] The Rate of Decrease in the Disease Activity of Rheumatoid Arthritis during Treatment with Adalimumab Depends on the Dose of Methotrexate
    Oh, Koei
    Ito, Satoshi
    Unno, Megumi
    Kobayashi, Daisuke
    Azuma, Chinatsu
    Abe, Asami
    Otani, Hiroshi
    Ishikawa, Hajime
    Nakazono, Kiyoshi
    Narita, Ichiei
    Murasawa, Akira
    INTERNAL MEDICINE, 2015, 54 (09) : 1035 - 1041
12345